AM Best Affirms Credit Ratings of Triple-S Management and Certain Life/Health Subsidiaries; Downgrades Credit Ratings of Triple-S Blue, Inc. I.I.
Furthermore, AM Best has downgraded the FSR to B+ (Good) from B++ (Good) and the Long-Term ICR to “bbb-” from “bbb” of
The ratings of TSS and TSV reflect the group’s aggregate balance sheet strength, which AM Best categorizes as very strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management (ERM).
The capital level at TSS has increased over the near term primarily driven by favorable operating results in 2019 from premium growth largely attributed to its Medicare Advantage segment’s membership growth. Its Medicaid segment has also performed well and attracted more members and higher average premium rates. TSS manages the largest provider network in
TSM has managed and prioritized its risks to minimize operational downtime. The company has managed operational risk well through two major hurricanes and earthquakes affecting the island’s infrastructure over the past couple of years. More recently, the organization was able to execute its contingency plans around business continuity following the COVID-19 pandemic spread. AM Best notes that the impact to health insurance companies from COVID-19 has been less severe than anticipated. After state and federal agencies requested the deferral of elective surgeries and routine care to limit the spread of the virus, health companies have seen a decline in medical care for non-COVID conditions, which has more than offset the impact from COVID-19 claims. AM Best acknowledges the risk management program for TSS and TSV to be appropriate with a formalized process, containing risk identification, management and mitigation.
TSV continues to have adequate capital capacity supporting its life claims experience. Furthermore, TSV has had a conservative investment portfolio and sustained overall liquidity above 100% during the past five years. A favorable long-term trend of operating results coupled with lower loss ratio has added to steady growth for this company.
The ratings of TSB reflect its balance sheet strength, which AM Best categorizes as adequate, as well as its marginal operating performance, limited business profile and appropriate ERM. The Long-Term ICR downgrade for TSB reflects its unfavorable operating results, which has led to the decline in its risk-adjusted capitalization. TSB’s outlook revision to negative is attributed to deterioration in the company’s operating results, as well as sustained decline in capitalization to a level that no longer supported the rating. The balance sheet strength assessment includes the explicit and implicit support of TSB’s parent company (TSV) and ultimate parent company (TSM). AM Best expects capital support from TSV as needed to support the growth of business.
TSB has made investments in its business operations to sustain additional growth and uses its
This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper media use of Best’s Credit Ratings and AM Best press releases, please view Guide for Media - Proper Use of Best’s Credit Ratings and AM Best Rating Action Press Releases.
AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in
Copyright © 2020 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200603005619/en/
+1 908 439 2200, ext. 5792
[email protected]
Manager, Public Relations
+1 908 439 2200, ext. 5159
[email protected]
Senior Financial Analyst
+1 908 439 2200, ext. 5061
[email protected]
Director, Public Relations
+1 908 439 2200, ext. 5644
[email protected]
Source: AM Best
Negative Pressure Wound Therapy Devices Market to Reach $3.34 Bn, by 2027, at 5.7% CAGR: Allied Market Research
Church Mutual® Announces Tentative Return-to-Work Plans
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News